JUNE 20, 2023
Newly Published Data Demonstrates Positive Outcomes Resulting from Pathnostics' Advanced Urinary Tract Infection (UTI) Test
May 2, 2023
Pathnostics Announces Publication in Research and Reports in Urology of its Interim Analysis for a Prospective Observational Study Evaluating Guidance® UTI in Patients with Complicated Urinary Tract Infections
NOVEMBER 17, 2022
Pathnostics Announces Opening of New Facility in Lake Mary Florida and Expansion of its Irvine California Laboratory and Headquarters
SEPTEMBER 28, 2022
DispatchHealth and Pathnostics Initiate Clinical Study to Compare Guidance UTI® Test to Standard Urine Culture Among Patients Receiving In-Home Care
May 16, 2022
Pathnostics to Present New Real-World Method to Identify and Evaluate Cost Outcomes of a Novel, Uncoded UTI Diagnostic at the International Society for Pharmacoeconomics and Outcomes Research 2022 Annual Meeting
MAY 14, 2022
New Real-World Evidence Shows Improvements in Outcomes and Reduction in Healthcare Costs with Guidance® UTI Precision Diagnostic Test Compared to Standard Urine Culture in Patients with Complicated Urinary Tract Infections
MAY 10, 2022
Pathnostics to Present New Real-World Data Analysis of its Guidance® UTI Precision Diagnostic Test at the 2022 American Urology Association Annual Meeting
MAY 20, 2020
Pathnostics Launches COVID-19 PCR Laboratory Test Designed to Detect Acute Infection
APR 15, 2020
New Large-Patient Study Reveals Significant Reduction in Hospital Admissions from Pathnostics Advanced UTI Test
FEB 27, 2019
Water Street Announces Strategic Investment in Pathnostics